LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
Technology Businesses for Sale
Warehouse & Storage Businesses for Sale
Restaurants for Sale
Banquet Halls & Catering Businesses for Sale
Consulting & Training Businesses for Sale
Digital Marketing Business for Sale
Real Estate & Property Management Companies for Sale
Healthcare & Medical Businesses for Sale
Cleaning & Janitorial Businesses for Sale
Travel Businesses for Sale
Beauty & Personal Care Franchises for Sale
Retail Franchise Opportunities
Entertainment & Recreation Franchise Opportunities
Automotive Franchises for Sale
Gift & Flower Shop Franchise Opportunities
Finance & Accounting Franchise Opportunities
Catering Franchise Opportunities
Gas Station & Car Wash Franchises for Sale
Healthcare & Medical Franchise Opportunities
Fitness & Wellness Franchises for Sale
Retail Buildings for Sale or Lease
Houses & Condos for Sale or Lease
Office Spaces for Sale or Rent
Medical Office Spaces for Sale or Rent
Industrial Units for Sale or Rent
Retail Spaces for Lease or Sale
Miscellaneous Properties for Sale or Lease
Apartment Buildings for Sale
Medical Buildings for Sale or Lease
Land & Developments for Sale
An email will be sent to registered email address.
Please select if you are: